PHARMACOGNOSY MCQ (TEST 3)
MULTIPLE CHOICE QUESTIONS
S. Y. B.PHARM (UNIT-4) SEM-IV
AS PER PCI SYLLABUS
1. As per Chinese medicine system, one of the vital five organs is ……
-
A) Skin
As per Chinese medicine system, one of the vital five organs is Lungs. "
2. As per Chinese medicine system, five elements are known as ……
As per Chinese medicine system, five elements are known as Wu Xing. .
3. “Yin and Yang” stand for ……
“Yin and Yang” stand for Cold and heat.
4. Amorphous solid alkaloid is ……
Amorphous solid alkaloid is Emetine. "
5. Example of dextrorotatory alkaloid is ……
Example of dextrorotatory alkaloid is Coniine. .
6.The fundamental principle of Homoeopathy is : .
The fundamental principle of Homoeopathy is like can be treated by like. .
7. Who coined the term Aromatherapy ?
Rene-maurice Gattefosse in 1928.
8. Aromatherapy provides the treatment by using :
Aromatherapy provides the treatment by using Essential oils.
9. Aromatherapy can be effected by ……
Aromatherapy can be effected by All of the above. .
10. The book entitled "The Secret of Life and Youth" is authored by
The book entitled "The Secret of Life and Youth" is authored by Maury. "
11. Optically inactive alkaloid is ……
Optically inactive alkaloid is Papaverine. .
12. Orange colour alkaloid is ……
Orange colour alkaloid is Betanidine. .
13. Volatile liquid alkaloid is ……
Volatile liquid alkaloid is Nicotine. .
14. Non-volatile liquid alkaloid is ……
Non-volatile liquid alkaloid is Pilocarpine. .
15. Secondary amino alkaloid is ……
Secondary amino alkaloid is Ephedrine. .
16. Pyrrolidine derivative alkaloid is ……
Pyrrolidine derivative alkaloid is Nicotine. .
17. Pilocarpine belongs to derivatives of alkaloid is ……
Pilocarpine belongs to derivatives of alkaloid is Imidazole. .
18. Vasicine belongs to derivatives of alkaloids is ……
Vasicine belongs to derivatives of alkaloids is Quinazolin. .
19. Tropolone derivative alkaloid is ……
Tropolone derivative alkaloid is Colchicine. .
20. Example of Proto alkaloid is ……
Example of Proto alkaloid is Mescaline. .
0 Comments